EUCRW

Eucrates Biomedical Acquisition Corp. Warrant
EUCRW

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EUCRW was delisted on the 26th of April, 2023.

Back to rankings

22 hedge funds and large institutions have $731K invested in Eucrates Biomedical Acquisition Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.25K
2
+$1.14K
3
+$736
4
CS
Clear Street
New York
+$107
5
Bank of America
Bank of America
North Carolina
+$7

Top Sellers

1
-$7.08K
2
-$1.75K
3
-$1.39K
4
OMC
Old Mission Capital
Illinois
-$891
5
PC
Periscope Capital
Ontario, Canada
-$851
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
26
Periscope Capital
Ontario, Canada
–
UBS Group
27
UBS Group
Switzerland
–
1
2